日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients

多发性骨髓瘤患者继发原发性恶性肿瘤的预后

Avivi, Irit; Vesole, David H; Davila-Valls, Julio; Usnarska-Zubkiewicz, Lidia; Olszewska-Szopa, Magdalena; Milunovic, Vibor; Baumert, Bartłomiej; Osękowska, Bogumiła; Kopińska, Anna; Gentile, Massimo; Puertas-Martinez, Borja; Robak, Paweł; Crusoe, Edvan; Rodriguez-Lobato, Luis Gerardo; Gajewska, Małgorzata; Varga, Gergely; Delforge, Michel; Cohen, Yael; Gozzetti, Alessandro; Pena, Camila; Shustik, Chaim; Mikala, Gabor; Zalac, Klara; Alexander, H Denis; Barth, Peter; Weisel, Katja; Martínez-López, Joaquín; Waszczuk-Gajda, Anna; Krzystański, Mateusz; Jurczyszyn, Artur

PB2039: INFLAMMATORY MARKERS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS - A SINGLE CENTRE STUDY

PB2039:血吞噬细胞性淋巴组织细胞增生症的炎症标志物——单中心研究

Hsieh, Monica; Kim, Diane; Peng, Defen; Schisler, Travis; Cook, Richard C; Bahlis, Nizar J; Samaras, Christy; Reece, Donna; Sebag, Michael; Matous, Jeffrey; Berdeja, Jesus; Shustik, Jesse; Schiller, Gary; Ganguly, Siddhartha; Song, Kevin; Seet, Christopher S; Acosta-Rivera, Mirelis; Quick, Donald; Anz, Bertrand; Fonseca, Gustavo; Flores, Unicel-Anne; Liu, Hongjuan; Gentili, Christian; Siegel, David; Goubran, Mariam; Spaner, Caroline; LI, Amanda; Zoref-Lorenz, Adi; Jordan, Michael; Chen, Luke Y C; Setiadi, Audi

Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study

伊布替尼联合利妥昔单抗对比安慰剂联合利妥昔单抗治疗华氏巨球蛋白血症:来自随机 III 期 iNNOVATE 研究的最终分析

Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Veronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V; Tam, Constantine S; Heffner, Leonard T; Varettoni, Marzia; Palomba, M Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS

P890:多发性骨髓瘤患者继发原发性恶性肿瘤的结局

Gramatges, Maria M; Winter, Stuart S; Avivi, I; H vesole, D; Dávila Valls, J; Usnarska-Zubkiewicz, L; Milunovic, V; Bogumiła Osękowska, B B; Kopińska, A; Gentile, M; MARTÍNEZ, B P; Robak, P; crusoe, E; LUIS GERARDO, R; Gajewska, M; Gergely, V; Delforge, M; Cohen, Y; Alessandro, G; peña, C; Shustik, C; Mikala, G; Žalac, K; Denis, A H; Peter, B; Weisel, K; martinez lopez, J; Waszczuk-Gajda, A; Krzystanski, M; Jurczyszyn, A

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

一项评估伊布替尼联合卡非佐米/地塞米松治疗复发/难治性多发性骨髓瘤患者的 1/2b 期研究的最终分析

Chari, Ajai; Cornell, Robert F; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V; Niesvizky, Ruben; Lunning, Matthew; Usmani, Saad Z; Anderson, Larry D Jr; Chhabra, Saurabh; Girnius, Saulius; Shustik, Chaim; Stuart, Robert; Lee, Yihua; Salman, Zeena; Liu, Emily; Valent, Jason

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

对于不适合移植的新诊断多发性骨髓瘤患者,持续使用来那度胺和低剂量地塞米松:FIRST试验加拿大/美国患者的亚组分析

Belch, Andrew; Bahlis, Nizar; White, Darrell; Cheung, Matthew; Chen, Christine; Shustik, Chaim; Song, Kevin; Tosikyan, Axel; Dispenzieri, Angela; Anderson, Kenneth; Brown, Diane; Robinson, Suzanne; Srinivasan, Shankar; Facon, Thierry

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

复发/难治性多发性骨髓瘤患者接受伊沙佐米联合来那度胺/地塞米松治疗后不良事件的管理

Kumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Mateos, Maria-Victoria; Ludwig, Heinz; Shustik, Chaim; Masszi, Tamas; Spencer, Andrew; Hájek, Roman; Romeril, Kenneth; Avivi, Irit; Liberati, Anna M; Minnema, Monique C; Einsele, Hermann; Lonial, Sagar; Berg, Deborah; Lin, Jianchang; Gupta, Neeraj; Esseltine, Dixie-Lee; Richardson, Paul G

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

复发/难治性慢性淋巴细胞白血病治疗进展

Shustik, C; Bence-Bruckler, I; Delage, R; Owen, C J; Toze, C L; Coutre, S

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

多发性骨髓瘤累及中枢神经系统:一项纳入172例患者的多中心回顾性研究

Jurczyszyn, Artur; Grzasko, Norbert; Gozzetti, Alessandro; Czepiel, Jacek; Cerase, Alfonso; Hungria, Vania; Crusoe, Edvan; Silva Dias, Ana Luiza Miranda; Vij, Ravi; Fiala, Mark A; Caers, Jo; Rasche, Leo; Nooka, Ajay K; Lonial, Sagar; Vesole, David H; Philip, Sandhya; Gangatharan, Shane; Druzd-Sitek, Agnieszka; Walewski, Jan; Corso, Alessandro; Cocito, Federica; Vekemans, Marie-Christine M; Atilla, Erden; Beksac, Meral; Leleu, Xavier; Davila, Julio; Badros, Ashraf; Aneja, Ekta; Abildgaard, Niels; Kastritis, Efstathios; Fantl, Dorotea; Schutz, Natalia; Pika, Tomas; Butrym, Aleksandra; Olszewska-Szopa, Magdalena; Usnarska-Zubkiewicz, Lidia; Usmani, Saad Z; Nahi, Hareth; Chim, Chor S; Shustik, Chaim; Madry, Krzysztof; Lentzsch, Suzanne; Swiderska, Alina; Helbig, Grzegorz; Guzicka-Kazimierczak, Renata; Lendvai, Nikoletta; Waage, Anders; Andersen, Kristian T; Murakami, Hirokazu; Zweegman, Sonja; Castillo, Jorge J

A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia

加拿大视角下的免疫球蛋白疗法在降低慢性淋巴细胞白血病感染并发症中的应用

Lachance, S; Christofides, A L; Lee, J K; Sehn, L H; Ritchie, B C; Shustik, C; Stewart, D A; Toze, C L; Haddad, E; Vinh, D C